|
Market Closed -
Nasdaq Stockholm
17:00:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 8.990 SEK | +0.11% |
|
+1.93% | -33.41% |
| 08-13 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 08-13 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 99.53M 10.27M 8.85M 8.38M 7.6M 14.25M 981M 14.32M 38.27M 499M 38.58M 37.73M 1.58B | P/E 2026 * |
-2.99x | P/E 2027 * | -2.48x |
|---|---|---|---|---|---|
| Enterprise Value | 91.53M 9.45M 8.14M 7.71M 6.99M 13.1M 902M 13.17M 35.2M 459M 35.48M 34.7M 1.45B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| VIVE | Delayed | |
Deutsche Boerse AG
| OMA | Delayed | |
|
CBOE
| 0N4A | Real-time | |
|
CBOE
| OASMs | Real-time | |
|
Börse Stuttgart
| OMA | Delayed |
Last Transcript : Vivesto AB
| 1 day | +0.11% | ||
| 1 week | +1.93% | ||
| Current month | +1.70% | ||
| 1 month | +2.39% | ||
| 3 months | +1.70% | ||
| 6 months | +12.38% | ||
| Current year | -33.41% |
| 1 week | 8.79 |  | 9.04 |
| 1 month | 8.5 | | 9.14 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 22/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 30/06/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 24/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 25/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 24/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/03/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/03/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +1.93% | -60.83% | -57.09% | 10.27M | |
| -0.65% | -2.93% | +47.52% | +87.34% | 994B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 640B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 454B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 337B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 261B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 246B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 204B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 190B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 178B | |
| Average | -0.65% | -4.99% | +12.38% | +31.11% | 350.48B | |
| Weighted average by Cap. | -0.51% | -4.42% | +29.87% | +55.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.2M -2.76M -2.61M -2.37M -4.44M -306M -4.46M -11.92M -156M -12.02M -11.75M -491M | -40M -4.13M -3.56M -3.37M -3.05M -5.73M -394M -5.76M -15.38M -201M -15.5M -15.16M -634M |
| Net Debt | -8M -826K -711K -674K -611K -1.15M -78.88M -1.15M -3.08M -40.13M -3.1M -3.03M -127M | -17M -1.75M -1.51M -1.43M -1.3M -2.43M -168M -2.45M -6.54M -85.28M -6.59M -6.44M -269M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | SEK 8.990 | +0.11% | 918 |
| 10/09/26 | SEK 8.980 | -0.22% | 6,457 |
| 09/09/26 | SEK 9.000 | +2.27% | 6,779 |
| 08/09/26 | SEK 8.800 | -2.00% | 3,017 |
| 07/09/26 | SEK 8.980 | +1.81% | 2,950 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
